194 related articles for article (PubMed ID: 29843087)
1. Persistence to direct oral anticoagulants for acute venous thromboembolism.
Dronkers CEA; Lijfering WM; Teichert M; van der Meer FJM; Klok FA; Cannegieter SC; Huisman MV
Thromb Res; 2018 Jul; 167():135-141. PubMed ID: 29843087
[TBL] [Abstract][Full Text] [Related]
2. Persistence of oral anticoagulant treatment for atrial fibrillation in the Netherlands: A surveillance study.
Zielinski GD; van Rein N; Teichert M; Klok FA; Rosendaal FR; van der Meer FJM; Huisman MV; Cannegieter SC; Lijfering WM
Res Pract Thromb Haemost; 2020 Jan; 4(1):141-153. PubMed ID: 31989096
[TBL] [Abstract][Full Text] [Related]
3. Case fatality of bleeding and recurrent venous thromboembolism during, initial therapy with direct oral anticoagulants: a systematic review.
Wu C; Alotaibi GS; Alsaleh K; Sean McMurtry M
Thromb Res; 2014 Sep; 134(3):627-32. PubMed ID: 25047174
[TBL] [Abstract][Full Text] [Related]
4. Anticoagulation therapy patterns for acute treatment of venous thromboembolism in GARFIELD-VTE patients.
Haas S; Ageno W; Weitz JI; Goldhaber SZ; Turpie AGG; Goto S; Angchaisuksiri P; Dalsgaard Nielsen J; Kayani G; Zaghdoun A; Farjat AE; Schellong S; Bounameaux H; Mantovani LG; Prandoni P; Kakkar AK
J Thromb Haemost; 2019 Oct; 17(10):1694-1706. PubMed ID: 31220403
[TBL] [Abstract][Full Text] [Related]
5. The role of heparin lead-in in the real-world management of acute venous thromboembolism: The PREFER in VTE registry.
Bauersachs R; Agnelli G; Gitt AK; Monreal M; Mismetti P; Willich SN; Laeis P; Fronk EM; Bramlage P; Cohen AT;
Thromb Res; 2017 Sep; 157():181-188. PubMed ID: 28780343
[TBL] [Abstract][Full Text] [Related]
6. Bleeding and thrombotic complications during treatment with direct oral anticoagulants or vitamin K antagonists in venous thromboembolic patients included in the prospective, observational START2-register.
Palareti G; Antonucci E; Legnani C; Mastroiacovo D; Poli D; Prandoni P; Tosetto A; Pengo V; Testa S; Ageno W;
BMJ Open; 2020 Nov; 10(11):e040449. PubMed ID: 33247017
[TBL] [Abstract][Full Text] [Related]
7. Case-fatality of recurrent venous thromboembolism and major bleeding associated with aspirin, warfarin, and direct oral anticoagulants for secondary prevention.
Wu C; Alotaibi GS; Alsaleh K; Linkins LA; McMurtry MS
Thromb Res; 2015 Feb; 135(2):243-8. PubMed ID: 25488466
[TBL] [Abstract][Full Text] [Related]
8. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
9. Direct oral anticoagulants in the treatment of acute venous thromboembolism: a systematic review and meta-analysis.
Gómez-Outes A; Terleira-Fernández AI; Lecumberri R; Suárez-Gea ML; Vargas-Castrillón E
Thromb Res; 2014 Oct; 134(4):774-82. PubMed ID: 25037495
[TBL] [Abstract][Full Text] [Related]
10. Safety and effectiveness of direct oral anticoagulants following ultrasound-assisted catheter directed thrombolysis for venous thromboembolism.
Kelley D; Wright L; Ohman K; Ferreira J
J Thromb Thrombolysis; 2018 Jul; 46(1):58-61. PubMed ID: 29797208
[TBL] [Abstract][Full Text] [Related]
11. Preference for direct oral anticoagulants in patients treated with vitamin K antagonists for venous thromboembolism.
Brekelmans MP; Kappelhof M; Nieuwkerk PT; Nierman M; Buller HR; Coppens M
Neth J Med; 2017 Mar; 75(2):50-55. PubMed ID: 28276323
[TBL] [Abstract][Full Text] [Related]
12. Direct oral anticoagulants in the treatment of acute venous thromboembolism in patients with obesity: A systematic review with meta-analysis.
Mai V; Marceau-Ferron E; Bertoletti L; Lacasse Y; Bonnet S; Lega JC; Provencher S
Pharmacol Res; 2021 Jan; 163():105317. PubMed ID: 33246169
[TBL] [Abstract][Full Text] [Related]
13. Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran.
Leung TS; Law EH
Drug Des Devel Ther; 2015; 9():3557-69. PubMed ID: 26185422
[TBL] [Abstract][Full Text] [Related]
14. Effect of body weight on efficacy and safety of direct oral anticoagulants in the treatment of patients with acute venous thromboembolism: a meta-analysis of randomized controlled trials.
Di Minno MN; Lupoli R; Di Minno A; Ambrosino P; Scalera A; Dentali F
Ann Med; 2015 Feb; 47(1):61-8. PubMed ID: 25665582
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness and Safety of Non-vitamin K Antagonist Oral Anticoagulants for Atrial Fibrillation and Venous Thromboembolism: A Systematic Review and Meta-analyses.
Almutairi AR; Zhou L; Gellad WF; Lee JK; Slack MK; Martin JR; Lo-Ciganic WH
Clin Ther; 2017 Jul; 39(7):1456-1478.e36. PubMed ID: 28668628
[TBL] [Abstract][Full Text] [Related]
16. Safety and efficacy of direct oral anticoagulants in patients with chronic thromboembolic pulmonary hypertension.
Benzidia I; Robitaille C; Abualsaud A; McDonald L; Lesenko L; Morin JF; Langleben D; Kahn SR; Hirsch A
Thromb Res; 2023 Sep; 229():139-145. PubMed ID: 37453256
[TBL] [Abstract][Full Text] [Related]
17. Very elderly patients with venous thromboembolism on oral anticoagulation with VKAs or DOACs: Results from the prospective multicenter START2-Register Study.
Poli D; Antonucci E; Bertù L; Vignini E; Ruocco L; Mastroiacovo D; Paparo C; Pastori D; Testa S; Ageno W; Palareti G;
Thromb Res; 2019 Nov; 183():28-32. PubMed ID: 31536872
[TBL] [Abstract][Full Text] [Related]
18. Asian patients versus non-Asian patients in the efficacy and safety of direct oral anticoagulants relative to vitamin K antagonist for venous thromboembolism: A systemic review and meta-analysis.
Yamashita Y; Morimoto T; Toyota T; Shiomi H; Makiyama T; Ono K; Kimura T
Thromb Res; 2018 Jun; 166():37-42. PubMed ID: 29655001
[TBL] [Abstract][Full Text] [Related]
19. Risks of postextraction bleeding after receiving direct oral anticoagulants or warfarin: a retrospective cohort study.
Yagyuu T; Kawakami M; Ueyama Y; Imada M; Kurihara M; Matsusue Y; Imai Y; Yamamoto K; Kirita T
BMJ Open; 2017 Aug; 7(8):e015952. PubMed ID: 28827248
[TBL] [Abstract][Full Text] [Related]
20. Major bleeding with vitamin K antagonists or direct oral anticoagulants in real-life.
Becattini C; Franco L; Beyer-Westendorf J; Masotti L; Nitti C; Vanni S; Manina G; Cattinelli S; Cappelli R; Sbrojavacca R; Pomero F; Marten S; Agnelli G
Int J Cardiol; 2017 Jan; 227():261-266. PubMed ID: 27843050
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
